Dr. Jagsi Discusses the Benefits of Hypofractionated Radiotherapy for Breast Cancer

Reshma Jagsi, MD, DPhil, associate professor, Department of Radiation Oncology, University of Michigan Health System, discusses the benefits of hypofractionated radiotherapy for patients with breast cancer.

Reshma Jagsi, MD, DPhil, associate professor, Department of Radiation Oncology, University of Michigan Health System, discusses the benefits of hypofractionated radiotherapy for patients with breast cancer.

Jagsi explains that hypofractionated radiaotherapy means giving radiation in larger doses per treatment so that treatment can be accomplished more quickly. An analysis conducted by Jagsi and her colleagues looked at the adoption of this approach over time because recent studies have established that hypofractionated radiotherapy are clinically equivalent to longer, standard courses of radiation therapy in the adjuvant treatment of many cases of early-stage breast cancer.

In selected patients, this approach may be a more convenient approach that is not inferior in terms of outcomes and might be preferable, Jagsi says.